After winning a surprise approval for its hereditary angioedema drug Ekterly, KalVista is confident the oral offering will capture the lion’s share of the market for on-demand use.
The obesity market and Most Favored Nation drug pricing were among the topics de jour at the J.P. Morgan Healthcare Conference last week, while smaller biotechs sought to assure investors that their regulatory ducks are in a row; Novo Nordisk’s oral obesity pill got off to a hot start while the FDA delayed a decision on Eli Lilly’s investigational offering; and SpyGlass Pharma and AgomAb Therapeutics join the 2026 IPO club.
At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific culture where you work.
Courses and certifications will include AI, RPA, cybersecurity, data analytics and visualization, financial planning and analysis, sustainability and leadership.
Lucas Horsfall integrated Gettleson, Witzer & O’Connor of Encino, California. Wilson Lewis merged in Alexander, Almand & Bangs of Gainesville, Georgia.
The Internal Revenue Service and the Treasury said the payment of $1,776 for members of the military announced by President Trump last month would not be taxed.
Recent data finds that a significant fraction of accounting firms are changing their organizational structures to optimize for AI, especially when it comes to junior roles.